Michelle L. Gagnon joined StrategyCorp as a Senior Advisor in 2020. To this role she brings many years of experience working with a variety of prominent organizations in both the public and private (philanthropic) sectors including the Policy Research Initiative in the Privy Council Office, the Canadian Institutes of Health Research (CIHR), Alberta Health Services, Strategic Clinical Networks and as President and CEO of the Palix Foundation and the Alberta Family Wellness Initiative. More recently, Michelle co-founded and is Chief Operating Officer of Pemi31Therapeutics Inc., a science forward biotech start-up focused on immune therapy for inflammatory diseases.
Combining both an academic and executive background, Michelle’s career has focused primarily on the health and social sectors, and in particular on mobilizing knowledge to inform policy, practice and program innovations to improve health and well-being. Michelle is a social scientist with an interdisciplinary doctoral degree in population health, a Master of Business Administration and undergraduate degrees in liberal arts and nursing. She also holds an adjunct position in the Cumming School of Medicine, Department of Community Health Sciences at the University of Calgary. Her research interests focus on public policy as a determinant of population and public health and on the policymaking process. Michelle is a member of the Institute of Corporate Directors (ICD). She completed the ICD-Rotman Directors Education Program in September 2018 and obtained the ICD.D designation in November 2018.
Throughout her career, as a credible thought leader with a broad perspective, Michelle has led, collaborated and built bridges across sectors, cultures and disciplines at the municipal, provincial, national and international levels to deliberate and find evidence informed solutions to important and complex public policy issues. Such issues include population and public health, health services quality and access, mental health and addiction prevention and treatment, early childhood development and supporting family and community resilience proactively and during times of crisis, like the COVID 19 pandemic. Over the years, she has regularly negotiated and been involved in public / private collaborations and worked with high ranking leaders from a variety of organizations, including in the community, business, post-secondary institutions and government, both in the bureaucracy and political offices. She excels in organizations and contexts undergoing change and rejuvenation.
Michelle is also active on Boards and committees, including as a member of the CIHR Institute Advisory Board on Health Promotion and Prevention, on the Board of Philanthropic Foundations Canada and as Co-Chair of St. Mary’s University Board of Governors in (Calgary).